Monitoring Immune Responses in IgA Nephropathy: Biomarkers to Guide Management
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Monitoring Immune Responses in IgA Nephropathy: Biomarkers to Guide Management
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-10-06
DOI
10.3389/fimmu.2020.572754
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Artificial intelligence and machine learning in nephropathology
- (2020) Jan U. Becker et al. KIDNEY INTERNATIONAL
- IgA nephropathy genetic risk score to estimate the prevalence of IgA nephropathy in UK Biobank
- (2020) Kittiya Sukcharoen et al. Kidney International Reports
- External validation of the international risk-prediction models of IgA nephropathy in an Asian-Caucasian cohort
- (2020) Yuemiao Zhang et al. Kidney International Reports
- Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy
- (2019) Aliza Thompson et al. Clinical Journal of the American Society of Nephrology
- Plasma acylcarnitines could predict prognosis and evaluate treatment of IgA nephropathy
- (2019) Fang-Ying Xia et al. Nutrition & Metabolism
- Evaluating a New International Risk-Prediction Tool in IgA Nephropathy
- (2019) Sean J. Barbour et al. JAMA Internal Medicine
- GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Meta-Analysis of Treatment Effects of Randomized Controlled Trials
- (2019) Lesley A. Inker et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Evaluating Glomerular Filtration Rate Slope as a Surrogate End Point for ESKD in Clinical Trials: An Individual Participant Meta-Analysis of Observational Data
- (2019) Morgan E. Grams et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
- (2019) Fernando C. Fervenza et al. NEW ENGLAND JOURNAL OF MEDICINE
- Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency
- (2019) Andrew S. Levey et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Plasma Galactose-Deficient IgA1 and C3 and CKD Progression in IgA Nephropathy
- (2019) Pei Chen et al. Clinical Journal of the American Society of Nephrology
- Neutrophil-to-lymphocyte ratio: An effective predictor of corticosteroid response in IgA nephropathy
- (2019) Hu Yang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression
- (2019) Xiaobing Yang et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Omics studies for comprehensive understanding of immunoglobulin A nephropathy: state-of-the-art and future directions
- (2018) Francesco Paolo Schena et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Urinary Exosomes and Exosomal CCL2 mRNA as Biomarkers of Active Histologic Injury in IgA Nephropathy
- (2018) Ye Feng et al. AMERICAN JOURNAL OF PATHOLOGY
- The landscape and diagnostic potential of T and B cell repertoire in Immunoglobulin A Nephropathy
- (2018) Chen Huang et al. JOURNAL OF AUTOIMMUNITY
- Serum levels of tumor necrosis factor alpha in patients with IgA nephropathy are closely associated with disease severity
- (2018) Guanhong Li et al. BMC Nephrology
- Serum Matrix Metalloproteinase-7 Level is Associated with Fibrosis and Renal Survival in Patients with IgA Nephropathy
- (2017) Jian Zhang et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group
- (2017) Hernán Trimarchi et al. KIDNEY INTERNATIONAL
- Copeptin, a surrogate marker for arginine vasopressin, is associated with disease severity and progression in IgA nephropathy patients
- (2017) Debbie Zittema et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Mycophenolate mofetil therapy in immunoglobulin A nephropathy: histological changes after treatment
- (2017) Hannah Beckwith et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- New insights into the pathogenesis of IgA nephropathy
- (2017) See Cheng Yeo et al. PEDIATRIC NEPHROLOGY
- Urinary Periostin Excretion Predicts Renal Outcome in IgA Nephropathy
- (2016) Jin Ho Hwang et al. AMERICAN JOURNAL OF NEPHROLOGY
- Measures of Urinary Protein and Albumin in the Prediction of Progression of IgA Nephropathy
- (2016) Y.-f. Zhao et al. Clinical Journal of the American Society of Nephrology
- Toward Noninvasive Diagnosis of IgA Nephropathy: A Pilot Urinary Metabolomic and Proteomic Study
- (2016) Michaela Neprasova et al. DISEASE MARKERS
- Elevated Plasmaα-Defensins (HNP1–3) Levels Correlated with IgA1 Glycosylation and Susceptibility to IgA Nephropathy
- (2016) Yuan-yuan Qi et al. DISEASE MARKERS
- Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
- (2016) Hitoshi Suzuki et al. DISEASE MARKERS
- MiR-100-3p and miR-877-3p regulate overproduction of IL-8 and IL-1β in mesangial cells activated by secretory IgA from IgA nephropathy patients
- (2016) Yan Liang et al. EXPERIMENTAL CELL RESEARCH
- Vitamin D-Binding Protein Is a Potential Urinary Biomarker of Irbesartan Treatment Response in Patients with IgA Nephropathy
- (2016) Jiashun Zeng et al. Genetic Testing and Molecular Biomarkers
- Immunoglobulin A nephropathy: a pathophysiology view
- (2016) Rafaela Cabral Gonçalves Fabiano et al. INFLAMMATION RESEARCH
- A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction
- (2016) Richard A. Lafayette et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- A Multicenter Study of the Predictive Value of Crescents in IgA Nephropathy
- (2016) Mark Haas et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The Clinical Significance of Uric Acid and Complement Activation in the Progression of IgA Nephropathy
- (2016) Yasar Caliskan et al. KIDNEY & BLOOD PRESSURE RESEARCH
- In a retrospective international study, circulating miR-148b and let-7b were found to be serum markers for detecting primary IgA nephropathy
- (2016) Grazia Serino et al. KIDNEY INTERNATIONAL
- Epidemiology of Glomerular Disease in Southern Arizona
- (2016) Sangeetha Murugapandian et al. MEDICINE
- Biomarkers and targeted new therapies for IgA nephropathy
- (2016) Rosanna Coppo PEDIATRIC NEPHROLOGY
- Vitamin D deficiency may predict a poorer outcome of IgA nephropathy
- (2016) Xiao-Hua Li et al. BMC Nephrology
- Serum Levels of Soluble ST2 and IL-10 Are Associated with Disease Severity in Patients with IgA Nephropathy
- (2016) Zhihui Zhang et al. Journal of Immunology Research
- Aberrant IgA1 Glycosylation in IgA Nephropathy: A Systematic Review
- (2016) Qiang Sun et al. PLoS One
- miR-21-5p renal expression is associated with fibrosis and renal survival in patients with IgA nephropathy
- (2016) Marie-Flore Hennino et al. Scientific Reports
- Proliferation and Cytokine Production of Human Mesangial Cells Stimulated by Secretory IgA Isolated from Patients with IgA Nephropathy
- (2015) Yan Liang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Predictors of outcome for severe IgA Nephropathy in a multi-ethnic U.S. cohort
- (2015) Ana Huerta Arroyo et al. CLINICAL NEPHROLOGY
- Hyperuricemia is associated with progression of IgA nephropathy
- (2015) Ali Bakan et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Role of IgA receptors in the pathogenesis of IgA nephropathy
- (2015) Sebastian M. Lechner et al. JOURNAL OF NEPHROLOGY
- Reversal of active glomerular lesions after immunosuppressive therapy in patients with IgA nephropathy: a repeat-biopsy based observation
- (2015) Xia-Hong Shen et al. JOURNAL OF NEPHROLOGY
- Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes
- (2015) Laureline Berthelot et al. KIDNEY INTERNATIONAL
- Long-term outcomes for primary glomerulonephritis: New Zealand Glomerulonephritis Study
- (2015) Caroline L Chembo et al. NEPHROLOGY
- Turnover of type III collagen reflects disease severity and is associated with progression and microinflammation in patients with IgA nephropathy
- (2015) Federica Genovese et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Altered monocyte expression and expansion of non-classical monocyte subset in IgA nephropathy patients
- (2015) Sharon N. Cox et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Intensive Supportive Care plus Immunosuppression in IgA Nephropathy
- (2015) Thomas Rauen et al. NEW ENGLAND JOURNAL OF MEDICINE
- High serum and urine neutrophil gelatinaseassociated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy
- (2015) Harin Rhee et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Urinary CXCL1: A Novel Predictor of IgA Nephropathy Progression
- (2015) Yanfeng Zhao et al. PLoS One
- Circulating TNF Receptors 1 and 2 Are Associated with the Severity of Renal Interstitial Fibrosis in IgA Nephropathy
- (2015) Yuji Sonoda et al. PLoS One
- Circulating Tumor Necrosis Factor α Receptors Predict the Outcomes of Human IgA Nephropathy: A Prospective Cohort Study
- (2015) Yun Jung Oh et al. PLoS One
- Serum levels of galactose-deficient immunoglobulin (Ig) A1 and related immune complex are associated with disease activity of IgA nephropathy
- (2014) Yusuke Suzuki et al. Clinical and Experimental Nephrology
- Association of C4d Deposition with Clinical Outcomes in IgA Nephropathy
- (2014) M. Espinosa et al. Clinical Journal of the American Society of Nephrology
- High uric acid level is a risk factor for progression of IgA nephropathy with chronic kidney disease stage G3a
- (2014) Takahito Moriyama et al. JOURNAL OF NEPHROLOGY
- Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments
- (2014) Rosanna Coppo et al. KIDNEY INTERNATIONAL
- Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens
- (2014) Krzysztof Kiryluk et al. NATURE GENETICS
- Urinary serum- and glucocorticoid-inducible kinase SGK1 reflects renal injury in patients with immunoglobulin A nephropathy
- (2014) Xiaoqian Lu et al. NEPHROLOGY
- Changes in Nephritogenic Serum Galactose-Deficient IgA1 in IgA Nephropathy following Tonsillectomy and Steroid Therapy
- (2014) Junichiro Nakata et al. PLoS One
- A Panel of Serum Biomarkers Differentiates IgA Nephropathy from Other Renal Diseases
- (2014) Hiroyuki Yanagawa et al. PLoS One
- Microbiota and Metabolome Associated with Immunoglobulin A Nephropathy (IgAN)
- (2014) Maria De Angelis et al. PLoS One
- The Molecular Phenotype of Endocapillary Proliferation: Novel Therapeutic Targets for IgA Nephropathy
- (2014) Jeffrey B. Hodgin et al. PLoS One
- Optimal Proteinuria Target for Renoprotection in Patients with IgA Nephropathy
- (2014) Ki Heon Nam et al. PLoS One
- Significance of Urinary Full-Length Megalin in Patients with IgA Nephropathy
- (2014) Takuto Seki et al. PLoS One
- Plasma uric acid level indicates tubular interstitial leisions at early stage of IgA nephropathy
- (2014) Jingjing Zhou et al. BMC Nephrology
- Urinary kidney injury molecule-1 is related to pathologic involvement in IgA nephropathy with normotension, normal renal function and mild proteinuria
- (2014) Peng-cheng Xu et al. BMC Nephrology
- Urinary excretion of β2-microglobulin as a prognostic marker in immunoglobulin A nephropathy
- (2014) Jae Ryung Shin et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Pathophysiology of proteinuria and its value as an outcome measure in CKD
- (2013) Paolo Cravedi et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Soluble transferrin receptor in urine, a new biomarker for IgA nephropathy and Henoch–Schönlein purpura nephritis
- (2013) Sigurd E. Delanghe et al. CLINICAL BIOCHEMISTRY
- Association of Urinary Laminin G-Like 3 and Free K Light Chains with Disease Activity and Histological Injury in IgA Nephropathy
- (2013) M. T. Rocchetti et al. Clinical Journal of the American Society of Nephrology
- Micro-RNA Expression in the Urinary Sediment of Patients with Chronic Kidney Diseases
- (2013) Cheuk-Chun Szeto et al. DISEASE MARKERS
- A higher frequency of CD4+CXCR5+ T follicular helper cells in patients with newly diagnosed IgA nephropathy
- (2013) Li Zhang et al. IMMUNOLOGY LETTERS
- MiR-223 downregulation promotes glomerular endothelial cell activation by upregulating importin α4 and α5 in IgA nephropathy
- (2013) Hao Bao et al. KIDNEY INTERNATIONAL
- IgA Nephropathy
- (2013) Robert J. Wyatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Urinary Prognostic Biomarkers and Classification of IgA Nephropathy by High Resolution Mass Spectrometry Coupled with Liquid Chromatography
- (2013) Shiva Kalantari et al. PLoS One
- Application of Oxford classification, and overexpression of transforming growth factor-β1 and immunoglobulins in immunoglobulin A nephropathy: correlation with World Health Organization classification of immunoglobulin A nephropathy in a Chinese patient cohort
- (2013) Hongxue Meng et al. Translational Research
- Increased plasma sVCAM-1 is associated with severity in IgA nephropathy
- (2013) Li Zhu et al. BMC Nephrology
- Effect of treatment on urinary kidney injury molecule-1 in IgA nephropathy
- (2013) Mi Seon Seo et al. BMC Nephrology
- Day-to-Day Variability in Spot Urine Protein-Creatinine Ratio Measurements
- (2012) Chetana N. Naresh et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Risk Stratification of Patients With IgA Nephropathy
- (2012) Sean J. Barbour et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Urinary miR-21, miR-29, and miR-93: Novel Biomarkers of Fibrosis
- (2012) Gang Wang et al. AMERICAN JOURNAL OF NEPHROLOGY
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
- (2012) Brad H. Rovin et al. ARTHRITIS AND RHEUMATISM
- Quantitative change of IgA hinge O-glycan composition is a novel marker of therapeutic responses of IgA nephropathy
- (2012) Hirotsugu Iwatani et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Urinary mannose-binding lectin is a biomarker for predicting the progression of immunoglobulin (Ig)A nephropathy
- (2012) L.-L. Liu et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- The complex of immunoglobulin A and uromodulin as a diagnostic marker for immunoglobulin A nephropathy
- (2012) Takashi Obara et al. Clinical and Experimental Nephrology
- FGF23, Albuminuria, and Disease Progression in Patients with Chronic IgA Nephropathy
- (2012) S. Lundberg et al. Clinical Journal of the American Society of Nephrology
- Relationships between Levels of Urinary Podocalyxin, Number of Urinary Podocytes, and Histologic Injury in Adult Patients with IgA Nephropathy
- (2012) R. Asao et al. Clinical Journal of the American Society of Nephrology
- Renal macrophage infiltration is associated with a poor outcome in IgA nephropathy
- (2012) GEB Silva et al. Clinics
- Urinary Proteome Analysis by Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry with Magnetic Beads for Identifying the Pathologic Presentation of Clinical Early IgA Nephropathy
- (2012) Qiang He et al. Journal of Biomedical Nanotechnology
- Abnormal miR-148b Expression Promotes Aberrant Glycosylation of IgA1 in IgA Nephropathy
- (2012) G. Serino et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Autoantibodies Targeting Galactose-Deficient IgA1 Associate with Progression of IgA Nephropathy
- (2012) F. Berthoux et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression
- (2012) Na Zhao et al. KIDNEY INTERNATIONAL
- Serum oxylipin profiles in IgA nephropathy patients reflect kidney functional alterations
- (2012) Angela M. Zivkovic et al. Metabolomics
- Pathogenesis of IgA nephropathy
- (2012) Kar Neng Lai Nature Reviews Nephrology
- Serum immunoglobulin A/C3 ratio predicts progression of immunoglobulin A nephropathy
- (2012) Jun Zhang et al. NEPHROLOGY
- Oxidative Stress, Macrophage Infiltration and CD163 Expression Are Determinants of Long-Term Renal Outcome in Macrohematuria-Induced Acute Kidney Injury of IgA Nephropathy
- (2012) Eduardo Gutiérrez et al. NEPHRON CLINICAL PRACTICE
- Decreased Circulating C3 Levels and Mesangial C3 Deposition Predict Renal Outcome in Patients with IgA Nephropathy
- (2012) Seung Jun Kim et al. PLoS One
- LG3 fragment of endorepellin is a possible biomarker of severity in IgA nephropathy
- (2012) Brigitte Surin et al. PROTEOMICS
- Recurrence from primary and secondary glomerulopathy after renal transplant
- (2012) Guillaume Canaud et al. TRANSPLANT INTERNATIONAL
- Urinary angiotensinogen as a predictive marker in patients with immunoglobulin A nephropathy
- (2011) Yang-Gyun Kim et al. Clinical and Experimental Nephrology
- Oxidative Stress and Galactose-Deficient IgA1 as Markers of Progression in IgA Nephropathy
- (2011) R. Camilla et al. Clinical Journal of the American Society of Nephrology
- Altered urinary excretion of aquaporin 2 in IgA nephropathy
- (2011) Maria Teresa Rocchetti et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Mice overexpressing BAFF develop a commensal flora–dependent, IgA-associated nephropathy
- (2011) Douglas D. McCarthy et al. JOURNAL OF CLINICAL INVESTIGATION
- Predicting the Risk for Dialysis or Death in IgA Nephropathy
- (2011) F. Berthoux et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The Pathophysiology of IgA Nephropathy
- (2011) H. Suzuki et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Urinary kidney injury molecule-1 in patients with IgA nephropathy is closely associated with disease severity
- (2011) P.-C. Xu et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy
- (2011) H. P. E. Peters et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Soluble interleukin-2 receptor alfa predicts renal outcome in IgA nephropathy
- (2011) S. Lundberg et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population
- (2011) W. Le et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- IgA nephropathy recurs early in the graft when assessed by protocol biopsy
- (2011) F. Ortiz et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Proteinuria: detection and role in native renal disease progression
- (2011) Jose Luis Gorriz et al. Transplantation Reviews
- Secretory IgA are elevated in both saliva and serum of patients with various types of primary glomerulonephritis
- (2010) G. ROSTOKER et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Galactose-Deficient IgA1 in African Americans with IgA Nephropathy: Serum Levels and Heritability
- (2010) M. C. Hastings et al. Clinical Journal of the American Society of Nephrology
- Posttransplant Recurrence of Primary Glomerulonephritis
- (2010) C. Ponticelli et al. Clinical Journal of the American Society of Nephrology
- Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy
- (2010) Mai T. Vuong et al. KIDNEY INTERNATIONAL
- Altered modulation of WNT–β-catenin and PI3K/Akt pathways in IgA nephropathy
- (2010) Sharon N. Cox et al. KIDNEY INTERNATIONAL
- Epidemiology, impact and preventive care of chronic kidney disease in Taiwan
- (2010) SHANG-JYH HWANG et al. NEPHROLOGY
- Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
- (2010) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of a uromodulin fragment for diagnosis of IgA nephropathy
- (2010) Jie Wu et al. RAPID COMMUNICATIONS IN MASS SPECTROMETRY
- The level of urinary secretory immunoglobulin A (sIgA) of patients with IgA nephropathy is elevated and associated with pathological phenotypes
- (2009) Y. Tan et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Response to ‘Comments on the Oxford classification of IgA nephropathy’
- (2009) Ian S.D. Roberts et al. KIDNEY INTERNATIONAL
- Urinary levels of epidermal growth factor, interleukin-6 and monocyte chemoattractant protein-1 may act as predictor markers of renal function outcome in immunoglobulin A nephropathy
- (2009) MARIA STANGOU et al. NEPHROLOGY
- Patients with IgA nephropathy exhibit high systemic PDGF-DD levels
- (2009) P. Boor et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study
- (2009) M. Goto et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Aberrant galactosylation of IgA1 is involved in the genetic susceptibility of Chinese patients with IgA nephropathy
- (2009) X. Lin et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Differential chemokine expression in tubular cells in response to urinary proteins from patients with nephrotic syndrome
- (2008) Zhao Huang et al. CYTOKINE
- Prediction of diagnosis of immunoglobulin a nephropathy prior to renal biopsy and correlation with urinary sediment findings and prognostic grading
- (2008) Kazutaka Nakayama et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Aberrant IgA1 Glycosylation Is Inherited in Familial and Sporadic IgA Nephropathy
- (2008) A. G. Gharavi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- CD19+CD5+ B Cells in Primary IgA Nephropathy
- (2008) H. Yuling et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy
- (2008) S. Shimozato et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy
- (2007) D.D. Torres et al. KIDNEY INTERNATIONAL
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started